Small Methods · 2023 · 18 citations · 31 references
PharmacyPharmaceuticsPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineControlled Release MechanismsNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsAnticancer Drug LoadingCancer NanotherapyControlled ReleaseDrug Delivery NanocarriersDrug Release MechanismsNanoparticle-based ChemotherapyProdrug NanoparticlesUpconversion Nanoparticles
Fusobacterium nucleatum (Fn) existing in the community of colorectal cancer (CRC) promotes CRC progression and causes chemotherapy resistance. Despite great efforts that have been made to overcome Fn-induced chemotherapy resistance by co-delivering antibacterial agents and chemotherapeutic drugs, increasing the drug-loading capacity and enabling controlled release of drugs remain challenging. In this study, a novel supramolecular upconversion nanoparticle (SUNP) is constructed by incorporating a positively charged polymer (PAMAM-LA-CD) with Fn inhibition capacity, a negatively charged platinum (IV) oxaliplatin prodrug (OXA-COOH), upconversion nanoparticle (UCNPs) and polyethylene glycol-azobenzene (PEG-Azo) to enhance drug-loading and enable on-demand drug release for drug-resistant CRC treatment. SUNPs exhibit high drug-loading capacity (30.8%) and good structural stability under normal physiological conditions, while disassembled upon exogenous NIR excitation and endogenous azo reductase in the CRC microenvironment to trigger drug release. In vitro and in vivo studies demonstrate that SUNPs presented good biocompatibility and robust performance to overcome chemoresistance, thereby significantly inhibiting Fn-infected cancer cell proliferation. This study leverages multiple dynamic chemical designs to integrate both advantages of drug loading and release in a single system, which provides a promising candidate for precision therapy of bacterial-related drug-resistant cancers.
31
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert et al. · Science · 2015 · 3.8K citations · Full text
Medicine, Immunology, Oncology +17
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère et al. · Science · 2015 · 3.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Ta-Chung Yu, Fangfang Guo, Yanan Yu et al. · Cell · 2017 · 2.2K citations · Full text
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
Chandra Sekhar Pedamallu, Ewa Sicińska, Thomas E. Clancy et al. · Science · 2017 · 1.5K citations
Medicine, Microbiology, Oncology +17